Genetic polymorphisms of TP53‐binding protein 1 (TP53BP1) gene and association with breast cancer risk

Naidu R, Har YC, Taib NAM. Genetic polymorphisms of TP53‐binding protein 1 (TP53BP1) gene and association with breast cancer risk. APMIS 2011; 119: 460–67.

[1]  Bin Li,et al.  Stimulation of p53-mediated Transcriptional Activation by the p53-binding Proteins, 53BP1 and 53BP2* , 1998, The Journal of Biological Chemistry.

[2]  Y. Nakanishi,et al.  Cigarette smoking, TP53 Arg72Pro, TP53BP1 Asp353Glu and the risk of lung cancer in a Japanese population. , 2010, Oncology reports.

[3]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.

[4]  Y. Shiloh ATM and related protein kinases: safeguarding genome integrity , 2003, Nature Reviews Cancer.

[5]  T. Rauch,et al.  53BP1 is a Positive Regulator of the BRCA1 Promoter , 2005, Cell cycle.

[6]  Jiri Bartek,et al.  53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer , 2002, Nature Cell Biology.

[7]  H. Bloom,et al.  Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.

[8]  R. Winqvist,et al.  Germline alterations in the 53BP1 gene in breast and ovarian cancer families. , 2007, Cancer letters.

[9]  J. Glover,et al.  Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1 , 2001, Nature Structural Biology.

[10]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[11]  S. Elledge,et al.  53BP1, a Mediator of the DNA Damage Checkpoint , 2002, Science.

[12]  S. West,et al.  Distinct functions of BRCA1 and BRCA2 in double-strand break repair , 2001, Breast Cancer Research.

[13]  D. Livingston,et al.  Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. , 2002, Genes & development.

[14]  R. Naidu,et al.  P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer. , 2007, Journal of experimental & clinical cancer research : CR.

[15]  Wei Zhang,et al.  Polymorphic TP53BP1 and TP53 Gene Interactions Associated with Risk of Squamous Cell Carcinoma of the Head and Neck , 2007, Clinical Cancer Research.

[16]  R. Naidu,et al.  Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development. , 2009, Oncology research.

[17]  P. Bugert,et al.  TP53-binding protein variants and breast cancer risk: a case-control study , 2005, Breast Cancer Research.

[18]  S. Ganesan,et al.  Evaluation of single nucleotide polymorphisms (SNPs) in the p53 binding protein 1 (TP53BP1) gene in breast cancer patients treated with breast-conserving surgery and whole-breast irradiation (BCS + RT). , 2009, International journal of radiation oncology, biology, physics.

[19]  S. Fields,et al.  Two cellular proteins that bind to wild-type but not mutant p53. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Donald L Weaver,et al.  Revision of the American Joint Committee on Cancer staging system for breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  T. Halazonetis,et al.  P53 Binding Protein 1 (53bp1) Is an Early Participant in the Cellular Response to DNA Double-Strand Breaks , 2000, The Journal of cell biology.

[22]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[23]  A. Sancar,et al.  Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. , 2004, Annual review of biochemistry.

[24]  Junjie Chen,et al.  Tumor Suppressor P53 Binding Protein 1 (53bp1) Is Involved in DNA Damage–Signaling Pathways , 2001, The Journal of cell biology.

[25]  Hongbing Shen,et al.  Joint effects of single nucleotide polymorphisms in P53BP1 and p53 on breast cancer risk in a Chinese population. , 2006, Carcinogenesis.